These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11898580)

  • 81. Anticoagulation and platelet antiaggregation therapy in stroke prevention.
    Chong JY; Mohr JP
    Curr Opin Neurol; 2005 Feb; 18(1):53-7. PubMed ID: 15655403
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Antithrombotic therapy for stroke prevention in patients with atrial fibrillation].
    Tomita F; Kohya T; Kitabatake A
    Nihon Rinsho; 2000 Jun; 58(6):1326-34. PubMed ID: 10879060
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.
    Vaduganathan M; Qamar A; Gupta A; Bajaj N; Golwala HB; Pandey A; Bhatt DL
    Am J Med; 2018 May; 131(5):575-577. PubMed ID: 29229471
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Filling the gap between science & clinical practice: prevention of stroke recurrence.
    Russolillo A; Di Minno MN; Tufano A; Prisco D; Di Minno G
    Thromb Res; 2012 Jan; 129(1):3-8. PubMed ID: 21907395
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
    Davis KA; Miyares MA; Dietrich E
    Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Role of Antiplatelet Therapy in Stroke Prevention in Patients With Atrial Fibrillation.
    Manaktala R; Kluger J
    J Am Osteopath Assoc; 2017 Dec; 117(12):761-771. PubMed ID: 29181519
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020.
    Gladstone DJ; Lindsay MP; Douketis J; Smith EE; Dowlatshahi D; Wein T; Bourgoin A; Cox J; Falconer JB; Graham BR; Labrie M; McDonald L; Mandzia J; Ngui D; Pageau P; Rodgerson A; Semchuk W; Tebbutt T; Tuchak C; van Gaal S; Villaluna K; Foley N; Coutts S; Mountain A; Gubitz G; Udell JA; McGuff R; Heran MKS; Lavoie P; Poppe AY;
    Can J Neurol Sci; 2022 May; 49(3):315-337. PubMed ID: 34140063
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease: JACC Scientific Expert Panel.
    Del Brutto VJ; Chaturvedi S; Diener HC; Romano JG; Sacco RL
    J Am Coll Cardiol; 2019 Aug; 74(6):786-803. PubMed ID: 31395130
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Update of secondary stroke prevention.
    Diener HC; Weimar C
    Nephrol Dial Transplant; 2009 Jun; 24(6):1718-24. PubMed ID: 19244225
    [No Abstract]   [Full Text] [Related]  

  • 91. Is There Still a Role for Dual Antiplatelet Therapy in the Secondary Prevention of Lacunar Stroke?
    Shoamanesh A
    Stroke; 2023 Sep; 54(9):2251-2253. PubMed ID: 37639517
    [No Abstract]   [Full Text] [Related]  

  • 92. Stroke Prevention in Cervical Artery Dissection.
    Gill R; Biller J
    Curr Cardiol Rep; 2021 Oct; 23(12):182. PubMed ID: 34687376
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Current issues in antiplatelet therapy for stroke prevention: the importance of stroke subtypes and differences between stroke and MI patients.
    Kirshner HS
    J Neurol; 2010 Nov; 257(11):1788-97. PubMed ID: 20652300
    [TBL] [Abstract][Full Text] [Related]  

  • 94. CADISS: a feasibility trial that answered its question.
    Kasner SE
    Lancet Neurol; 2015 Apr; 14(4):342-3. PubMed ID: 25684165
    [No Abstract]   [Full Text] [Related]  

  • 95. Management of Embolic Stroke of Undetermined Source (ESUS).
    Geisler T; Mengel A; Ziemann U; Poli S
    Drugs; 2018 Jun; 78(8):823-831. PubMed ID: 29737498
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Embolic stroke of undetermined source].
    Vinogradov OI; Jablonskij MA; Kuznecov AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12. Vyp. 2):42-48. PubMed ID: 33449532
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Secondary prevention of stroke according to PRoFESS and SPARCL].
    Sander D; Etgen T
    Internist (Berl); 2009 Nov; 50(11):1227-38. PubMed ID: 19830399
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Secondary prevention of cardiovascular and cerebrovascular complications after ischemic stroke].
    Ostroumova OD; Bondarets OV
    Kardiologiia; 2014; 54(5):80-7. PubMed ID: 25177893
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Long-term therapy to prevent stroke.
    Kirshner HS; Biller J; Callahan AS
    J Am Board Fam Pract; 2005; 18(6):528-40. PubMed ID: 16322415
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Antithrombotic drugs in secondary stroke prevention: still some way to go.
    Diener HC; Rothwell PM
    Lancet; 2022 Sep; 400(10357):974-975. PubMed ID: 36063822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.